The proteasome is involved in the degradation of different aquaporin-2 mutants causing nephrogenic diabetes insipidus

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 111-120

  Hirano, Kiyoko ^b   Zuber, Christian ^b   Roth, Jürgen ^a   Ziak, Martin ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; MUTANT PROTEIN; PROTEASOME;

ANIMAL CELL; ARTICLE; CELL CLONE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGRADATION KINETICS; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GOLGI COMPLEX; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LIVER CELL; LYSOSOME; MUTATION; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; QUALITY CONTROL; RAT;

EID: 0038307139     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63635-8     Document Type: Article

References (46)

1. Ellgaard L, Molinari M, Helenius A: Setting the standards: quality control in the secretory pathway. Science 1999, 286:1882-1888
2. Roth J, Zuber C, Guhl B, Fan JY, Ziak M: The importance of trimming reactions on asparagine-linked oligosaccharides for protein quality control. Histochem Cell Biol 2002, 117:159-169
3. Parodi AJ: Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J 2000, 348:1-13
4. Tsai B, Ye YH, Rapoport TA: Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 2002, 3:246-255
5. Sommer T, Wolf DH: Endoplasmic reticulum degradation: reverse protein flow of no return. EMBO J 1997, 11:1227-1233
6. Bonifacino JS, Weissman AM: Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol 1998, 14:19-57
7. Brodsky JL, McCracken AA: ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol 1999, 10: 507-513
8. Aridor M, Hannan LA: Traffic jams II: an update of diseases of intracellular transport. Traffic 2002, 3:781-790
9. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994, 264:92-95
10. Canfield MC, Tamarappoo BK, Moses AM, Verkman AS, Holtzman EJ: Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 1997, 6:1865-1871
11. Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 2001, 63:607-630
12. van Lieburg AF, Knoers NV, Monnens LA: Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1999, 10:1958-1964
13. Ishibashi K, Kuwahara M, Sasaki S: Molecular biology of aquaporins. Reviews of Physiology Biochem. Edited by MP Blaustein, R Greger, H Grunicke, R Jahn, WJ Lederer, LM Mendell, A Miyajima, N Pfanner, G Schultz, M Schweiger Berlin, Springer-Verlag, 2000, pp 1-32
14. Verkman AS, Mitra AK: Structure and function of aquaporin water channels. Am J Physiol 2000, 278:F13-F28
15. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S: Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 1993, 361:549-552
16. Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW: Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 1993, 90:11663-11667
17. Marples D, Knepper MA, Christensen EI, Nielsen S: Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol 1995, 38:C655-C664
18. Katsura T, Verbavatz JM, Farinas J, Ma T, Ausiello DA, Verkman AS, Brown D: Constitutive and regulated membrane expression of aquaporin 1 and aquaporin 2 water channels in stably transfected LLC-PK1 epithelial cells. Proc Natl Acad Sci USA 1995, 92:7212-7216
19. Baumgarten R, Van De Pol MH, Wetzels JF, Van Os CH, Deen PM: Glycosylation is not essential for vasopressin-dependent routing of aquaporin-2 in transfected Madin-Darby canine kidney cells. J Am Soc Nephrol 1998, 9:1553-1559
20. Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH: Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 1995, 95:2291-2296
21. Tamarappoo BK, Verkman AS: Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 1998, 101:2257-2267
22. Tamarappoo BK, Yang B, Verkman AS: Misfolding of mutant aquaporin-2 water channels in nephrogenic diabetes insipidus. J Biol Chem 1999, 274:34825-34831
23. Yamauchi K, Fushimi K, Yamashita Y, Shinbo I, Sasaki S, Marumo F: Effects of missense mutations on rat aquaporin-2 in LLC-PK1 porcine kidney cells. Kidney Int 1999, 56:164-171
24. Mulders SM, Bichet DG, Rijss JPL, Kamsteeg EJ, Arthus MF, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, vanderSluijs P, vanOs CH, Deen PMT: An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998, 102:57-66
25. Mulders SM, Knoers NV, Van Lieburg AF, Monnens LA, Leumann E, Wuhl E, Schober E, Rijss JP, Van Os CH, Deen PM: New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 1997, 8:242-248
26. Hirano K, Roth J, Zuber C, Ziak M: Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation. Histochem Cell Biol 2002, 117:41-53
27. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
28. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, Frokiaer J, Nielsen S: Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun 2000, 276:1118-1128
29. Kamsteeg EJ, Wormhoudt TA, Rijss JP, van Os CH, Deen PM: An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 1999, 18:2394-2400
30. Levin MH, Haggie PM, Vetrivel L, Verkman AS: Diffusion in the endoplasmic reticulum of an aquaporin-2 mutant causing human nephrogenic diabetes insipidus. J Biol Chem 2001, 276:21331-21336
31. Yang BX, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS: Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus. J Biol Chem 2001, 276:2775-2779
32. deVirgilio M, Kitzmuller C, Schwaiger E, Klein M, Kreibich G, Ivessa NE: Degradation of a short-lived glycoprotein from the lumen of the endoplasmic reticulum: the role of N-linked glycans and the unfolded protein response. Mol Biol Cell 1999, 10:4059-4073
33. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR: Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996, 271:635-638
34. Burrows JA, Willis LK, Perlmutter DH: Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA 2000, 97:1796-1801
35. Egan ME, Glöckner-Pagel J, Ambrose CA, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ: Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 2002, 8:485-492
36. Fan JQ, Ishii S, Asano N, Suzuki Y: Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 1999, 5:112-115
37. Dormer RL, Derand R, McNeilly CM, Mettey Y, Bulteau Pignoux L, Metaye T, Vierfond JM, Gray MA, Galietta LJV, Morris MR, Pereira MMC, Doull IJM, Becq F, McPherson MA: Correction of deIF508-CFTR activity with benzo(C)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J Cell Sci 2001, 114:4073-4081
38. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roettne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN: Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002, 417: 254-259
39. Jakob CA, Burda P, teHeesen S, Aebi M, Roth J: Genetic tailoring of N-linked oligosaccharides: the role of glucose residues in glycoprotein processing of Saccharomyces cerevisiae in vivo. Glycobiology 1998, 8:155-164
40. Jakob CA, Burda P, Roth J, Aebi M: Degradation of misfolded endoplasmic reticulum glycoproteins in Saccharomyces cerevisiae is determined by a specific oligosaccharide structure. J Cell Biol 1998, 142:1223-1233
41. Liu Y, Choudhury P, Cabral CM, Sifers RN: Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem 1999, 274:5861-5867
42. Fagioli C, Sitia R: Glycoprotein quality control in the endoplasmic reticulum-mannose trimming by endoplasmic reticulum mannosidase I times the proteasomal degradation of unassembled immunoglobulin subunits. J Biol Chem 2001, 276:12885-12892
43. Marr N, Bichet DG, Lonergan M, Arthus MF, Jeck N, Seyberth HW, Rosenthal W, vanOs CH, Oksche A, Deen PMT: Heteroligomerization of an aquaporin-2 mutant with wild-type aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 2002, 11:779-789
44. Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, Vandewalle A, Feraille E, Martin PY: Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem 2002, 277:10379-10386
45. Hicke L: Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 1999, 9:107-112
46. van Kerkhof P, dosSantos CMA, Sachse M, Klumperman J, Bu GJ, Strous GJ: Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol Biol Cell 2001, 12:2556-2566